Fully automated, ultra-high-volume line providing sub-second cycle time, medical-grade precision, and scalable capacity ...
By Karen Roman GlucoTrack, Inc. (Nasdaq: GCTK) said the U.S. Patent and Trademark Office issued three patents for its continuous blood glucose monitoring platform as the company moves toward ...
Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with ...
[28 January 2026]: Roche Diagnostics Middle East presented a landmark launch event revealing Accu-Chek SmartGuide, a ...
Investing.com -- Glucotrack Inc. (NASDAQ:GCTK) stock surged 60% Thursday after the company announced that the U.S. Patent and ...
Letitia explains how a small medical device, designed to help manage the illness, is now blamed for sending hundreds of ...
Glucotrack, Inc.("Glucotrack", or the "Company") (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization ...
Khaleej Times on MSN
How AI is redefining care for 1.3 million diabetes patients in the UAE
Diabetes is one of the fastest-growing health challenges facing the UAE and the wider Gulf. More than 1.3 million adults in ...
WAN CHAI, WAN CHAI, HONG KONG, January 23, 2026 /EINPresswire.com/ -- Even with the advancement of Automated Insulin ...
As Bluetooth and other wireless technologies enable continuous health monitoring, the lines between consumer and medical ...
Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results